| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Galactosemias | 53 | 2023 | 124 | 11.710 |
Why?
|
| UTP-Hexose-1-Phosphate Uridylyltransferase | 28 | 2022 | 68 | 4.880 |
Why?
|
| Galactose | 34 | 2022 | 297 | 3.140 |
Why?
|
| Metabolism, Inborn Errors | 12 | 2023 | 284 | 2.280 |
Why?
|
| Inositol | 20 | 2016 | 215 | 1.950 |
Why?
|
| Symporters | 15 | 2016 | 363 | 1.920 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 14 | 2024 | 283 | 1.610 |
Why?
|
| Phosphatidylinositols | 12 | 2016 | 282 | 1.380 |
Why?
|
| Galactokinase | 4 | 2020 | 17 | 1.290 |
Why?
|
| Phenylketonurias | 5 | 2024 | 126 | 1.200 |
Why?
|
| Congenital Disorders of Glycosylation | 6 | 2024 | 50 | 0.990 |
Why?
|
| Ammonia | 11 | 2020 | 237 | 0.940 |
Why?
|
| Maple Syrup Urine Disease | 8 | 2018 | 40 | 0.910 |
Why?
|
| Infertility | 3 | 2023 | 654 | 0.800 |
Why?
|
| UDPglucose 4-Epimerase | 5 | 2022 | 14 | 0.780 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2019 | 1188 | 0.750 |
Why?
|
| Heat-Shock Proteins | 7 | 2003 | 795 | 0.720 |
Why?
|
| Lipid Metabolism, Inborn Errors | 5 | 2023 | 123 | 0.710 |
Why?
|
| Mitochondrial Diseases | 4 | 2018 | 343 | 0.700 |
Why?
|
| Erythrocytes | 13 | 2019 | 2413 | 0.650 |
Why?
|
| Dicarboxylic Acid Transporters | 1 | 2018 | 4 | 0.650 |
Why?
|
| Hyperammonemia | 6 | 2020 | 76 | 0.650 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2018 | 506 | 0.630 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 158 | 0.580 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 298 | 0.570 |
Why?
|
| Succinate-CoA Ligases | 1 | 2016 | 6 | 0.560 |
Why?
|
| Enzyme Assays | 3 | 2019 | 104 | 0.560 |
Why?
|
| Infant, Newborn | 56 | 2023 | 26202 | 0.560 |
Why?
|
| Hypogonadism | 1 | 2023 | 798 | 0.540 |
Why?
|
| Brain Diseases, Metabolic | 3 | 2012 | 44 | 0.510 |
Why?
|
| Hemiplegia | 1 | 2016 | 136 | 0.510 |
Why?
|
| Muscle Hypotonia | 2 | 2016 | 161 | 0.510 |
Why?
|
| Chromatography, High Pressure Liquid | 9 | 2017 | 1541 | 0.510 |
Why?
|
| Galactitol | 5 | 2001 | 6 | 0.510 |
Why?
|
| Neonatal Screening | 7 | 2023 | 597 | 0.500 |
Why?
|
| Chromatography, Liquid | 5 | 2020 | 983 | 0.500 |
Why?
|
| Urea Cycle Disorders, Inborn | 3 | 2020 | 32 | 0.490 |
Why?
|
| Lithium | 3 | 2013 | 596 | 0.480 |
Why?
|
| Alleles | 6 | 2022 | 6864 | 0.480 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2018 | 243 | 0.480 |
Why?
|
| Phenotype | 23 | 2022 | 16592 | 0.470 |
Why?
|
| Infant | 68 | 2024 | 36193 | 0.470 |
Why?
|
| Quadriplegia | 1 | 2016 | 226 | 0.470 |
Why?
|
| Apnea | 3 | 2008 | 195 | 0.470 |
Why?
|
| Oxidation-Reduction | 13 | 2023 | 2231 | 0.470 |
Why?
|
| Cataract | 1 | 2020 | 832 | 0.460 |
Why?
|
| Alopecia | 1 | 2018 | 412 | 0.460 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2014 | 102 | 0.450 |
Why?
|
| Rhabdomyolysis | 3 | 2020 | 152 | 0.440 |
Why?
|
| Fatty Acids | 9 | 2023 | 1808 | 0.440 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2014 | 141 | 0.430 |
Why?
|
| Carrier Proteins | 8 | 2020 | 4937 | 0.430 |
Why?
|
| Methylmalonyl-CoA Mutase | 3 | 2014 | 23 | 0.410 |
Why?
|
| Uridine Diphosphate Galactose | 10 | 2010 | 21 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2000 | 228 | 0.410 |
Why?
|
| Metabolic Diseases | 6 | 2018 | 683 | 0.400 |
Why?
|
| Homozygote | 10 | 2022 | 1776 | 0.400 |
Why?
|
| Brain | 23 | 2018 | 27121 | 0.400 |
Why?
|
| Child, Preschool | 66 | 2024 | 42232 | 0.390 |
Why?
|
| Genotype | 14 | 2022 | 12990 | 0.390 |
Why?
|
| Cryptorchidism | 1 | 2012 | 151 | 0.390 |
Why?
|
| Humans | 201 | 2024 | 761596 | 0.390 |
Why?
|
| Homocystinuria | 2 | 2010 | 64 | 0.380 |
Why?
|
| Lactation | 1 | 2014 | 397 | 0.380 |
Why?
|
| Genetic Variation | 4 | 2021 | 6567 | 0.380 |
Why?
|
| Fanconi Syndrome | 2 | 2005 | 34 | 0.380 |
Why?
|
| Uridine Diphosphate Glucose | 8 | 2010 | 22 | 0.380 |
Why?
|
| Nutrition Disorders | 2 | 2008 | 205 | 0.380 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2014 | 262 | 0.370 |
Why?
|
| Ovary | 2 | 2023 | 959 | 0.370 |
Why?
|
| Child Development | 2 | 2021 | 2306 | 0.370 |
Why?
|
| Liver Diseases | 2 | 2018 | 1297 | 0.360 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 3 | 2020 | 32 | 0.360 |
Why?
|
| Mutation | 24 | 2021 | 30053 | 0.360 |
Why?
|
| Asbestos, Crocidolite | 2 | 2014 | 18 | 0.360 |
Why?
|
| Urea | 5 | 2020 | 443 | 0.350 |
Why?
|
| Pentose Phosphate Pathway | 2 | 2020 | 126 | 0.350 |
Why?
|
| Child | 78 | 2024 | 80158 | 0.340 |
Why?
|
| Membrane Proteins | 9 | 2012 | 7859 | 0.330 |
Why?
|
| Mitochondrial Proteins | 2 | 2020 | 976 | 0.320 |
Why?
|
| Dystonia | 1 | 2012 | 370 | 0.310 |
Why?
|
| Metabolome | 2 | 2014 | 989 | 0.310 |
Why?
|
| Marfan Syndrome | 1 | 2010 | 236 | 0.310 |
Why?
|
| Triglycerides | 4 | 2023 | 2461 | 0.310 |
Why?
|
| Developmental Disabilities | 5 | 2021 | 1509 | 0.300 |
Why?
|
| Reproduction | 1 | 2012 | 645 | 0.300 |
Why?
|
| Glycosylation | 7 | 2024 | 1097 | 0.300 |
Why?
|
| Brain Chemistry | 4 | 2011 | 960 | 0.300 |
Why?
|
| Male | 121 | 2024 | 360846 | 0.300 |
Why?
|
| DNA Fingerprinting | 1 | 2008 | 114 | 0.290 |
Why?
|
| Female | 115 | 2024 | 392705 | 0.290 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1120 | 0.290 |
Why?
|
| Behavior, Animal | 6 | 2016 | 1878 | 0.280 |
Why?
|
| Galactosephosphates | 5 | 2012 | 9 | 0.280 |
Why?
|
| Fertility | 3 | 2023 | 771 | 0.270 |
Why?
|
| Glucose Transporter Type 2 | 2 | 2005 | 61 | 0.270 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 4 | 2007 | 23 | 0.270 |
Why?
|
| Nutrition Therapy | 1 | 2008 | 102 | 0.270 |
Why?
|
| Phenylacetates | 3 | 2017 | 112 | 0.270 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 520 | 0.270 |
Why?
|
| Adolescent | 56 | 2024 | 88326 | 0.270 |
Why?
|
| Transaldolase | 2 | 2020 | 10 | 0.260 |
Why?
|
| Ribosomal Proteins | 1 | 2008 | 371 | 0.260 |
Why?
|
| Glycogen Storage Disease | 2 | 2018 | 41 | 0.260 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 2 | 2004 | 14 | 0.260 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2017 | 3769 | 0.250 |
Why?
|
| Lung Transplantation | 4 | 2000 | 1310 | 0.250 |
Why?
|
| Glutamine | 2 | 2017 | 577 | 0.250 |
Why?
|
| Pleural Neoplasms | 3 | 2014 | 609 | 0.250 |
Why?
|
| Seizures | 7 | 2020 | 2957 | 0.250 |
Why?
|
| Mass Spectrometry | 8 | 2020 | 2192 | 0.250 |
Why?
|
| Phosphatidylcholines | 1 | 2006 | 405 | 0.250 |
Why?
|
| Coenzyme A-Transferases | 2 | 2001 | 7 | 0.240 |
Why?
|
| Coma | 6 | 2017 | 484 | 0.240 |
Why?
|
| Epilepsy | 5 | 2020 | 3290 | 0.240 |
Why?
|
| DNA, Mitochondrial | 5 | 2016 | 865 | 0.240 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2024 | 28 | 0.240 |
Why?
|
| Amenorrhea | 1 | 2008 | 483 | 0.230 |
Why?
|
| Mesothelioma | 3 | 2014 | 807 | 0.230 |
Why?
|
| Phosphotransferases (Phosphomutases) | 1 | 2023 | 8 | 0.230 |
Why?
|
| Fructose Intolerance | 1 | 2023 | 8 | 0.230 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2947 | 0.220 |
Why?
|
| Diabetic Nephropathies | 2 | 2014 | 973 | 0.220 |
Why?
|
| Pyruvate Dehydrogenase Complex Deficiency Disease | 1 | 2003 | 15 | 0.220 |
Why?
|
| Mining | 1 | 2004 | 93 | 0.220 |
Why?
|
| Peritoneal Neoplasms | 2 | 2014 | 711 | 0.220 |
Why?
|
| Gene Deletion | 4 | 2014 | 2665 | 0.210 |
Why?
|
| Adult | 72 | 2024 | 221210 | 0.210 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 4948 | 0.210 |
Why?
|
| Lipodystrophy | 1 | 2024 | 145 | 0.210 |
Why?
|
| Phenylalanine | 1 | 2024 | 366 | 0.210 |
Why?
|
| Sudden Infant Death | 2 | 2017 | 292 | 0.210 |
Why?
|
| Primary Ovarian Insufficiency | 3 | 2017 | 107 | 0.210 |
Why?
|
| Carnitine | 5 | 2017 | 252 | 0.200 |
Why?
|
| Pyruvic Acid | 1 | 2003 | 204 | 0.200 |
Why?
|
| Enzyme Stability | 2 | 2014 | 219 | 0.200 |
Why?
|
| Sugar Acids | 2 | 1998 | 24 | 0.200 |
Why?
|
| Breath Tests | 5 | 2004 | 299 | 0.200 |
Why?
|
| Heart Arrest | 1 | 2012 | 1514 | 0.200 |
Why?
|
| Bumetanide | 2 | 2013 | 98 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2018 | 15936 | 0.190 |
Why?
|
| Point Mutation | 8 | 2020 | 1595 | 0.190 |
Why?
|
| Jaw Abnormalities | 1 | 2021 | 27 | 0.190 |
Why?
|
| Liver | 12 | 2018 | 7528 | 0.190 |
Why?
|
| Mice | 24 | 2024 | 81539 | 0.190 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2021 | 8 | 0.190 |
Why?
|
| Dihydroorotase | 1 | 2021 | 8 | 0.190 |
Why?
|
| Sodium-Glucose Transporter 1 | 2 | 2014 | 108 | 0.190 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2021 | 19 | 0.190 |
Why?
|
| Glutamate-Ammonia Ligase | 2 | 2000 | 75 | 0.190 |
Why?
|
| Phosphoric Monoester Hydrolases | 4 | 2016 | 412 | 0.190 |
Why?
|
| Facies | 2 | 2018 | 222 | 0.190 |
Why?
|
| Reflex, Abnormal | 1 | 2021 | 83 | 0.180 |
Why?
|
| Apraxias | 1 | 2021 | 59 | 0.180 |
Why?
|
| Citrulline | 3 | 2001 | 106 | 0.180 |
Why?
|
| Glycerol | 2 | 2019 | 274 | 0.180 |
Why?
|
| Transketolase | 1 | 2020 | 9 | 0.180 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2001 | 46 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 7 | 2016 | 4740 | 0.180 |
Why?
|
| Amino Acids, Branched-Chain | 3 | 2014 | 269 | 0.180 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 3 | 2001 | 17 | 0.180 |
Why?
|
| Synaptosomes | 5 | 1986 | 116 | 0.180 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 12 | 0.180 |
Why?
|
| Uridine | 1 | 2021 | 141 | 0.180 |
Why?
|
| Duane Retraction Syndrome | 1 | 2021 | 59 | 0.180 |
Why?
|
| Young Adult | 20 | 2024 | 59260 | 0.180 |
Why?
|
| Arthrogryposis | 1 | 2021 | 68 | 0.180 |
Why?
|
| Abnormalities, Multiple | 4 | 2022 | 1423 | 0.180 |
Why?
|
| Fructose | 2 | 2023 | 288 | 0.180 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 27 | 0.180 |
Why?
|
| Carbon-Nitrogen Ligases | 2 | 2018 | 27 | 0.180 |
Why?
|
| Animals | 43 | 2024 | 168475 | 0.180 |
Why?
|
| Mannosidase Deficiency Diseases | 1 | 2019 | 3 | 0.180 |
Why?
|
| Basal Ganglia | 3 | 2003 | 554 | 0.170 |
Why?
|
| alpha-Mannosidase | 1 | 2019 | 20 | 0.170 |
Why?
|
| Optic Atrophy | 1 | 2020 | 79 | 0.170 |
Why?
|
| Registries | 4 | 2022 | 8225 | 0.170 |
Why?
|
| Pregnancy | 8 | 2023 | 29890 | 0.170 |
Why?
|
| Ophthalmoplegia | 1 | 2021 | 168 | 0.170 |
Why?
|
| Blepharoptosis | 1 | 2021 | 144 | 0.170 |
Why?
|
| Death, Sudden | 1 | 2022 | 301 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1924 | 0.170 |
Why?
|
| Molecular Biology | 1 | 2023 | 576 | 0.170 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2021 | 167 | 0.170 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 183 | 0.170 |
Why?
|
| Fatal Outcome | 4 | 2016 | 1835 | 0.170 |
Why?
|
| Craniofacial Abnormalities | 1 | 2022 | 319 | 0.170 |
Why?
|
| Hypoglycemia | 3 | 2020 | 883 | 0.170 |
Why?
|
| Occupational Exposure | 2 | 2014 | 1813 | 0.170 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2022 | 477 | 0.160 |
Why?
|
| Sodium | 2 | 2003 | 1588 | 0.160 |
Why?
|
| Propionates | 1 | 2000 | 183 | 0.160 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 2016 | 110 | 0.160 |
Why?
|
| Glycerol Kinase | 1 | 2018 | 17 | 0.160 |
Why?
|
| Glycocalyx | 1 | 2020 | 97 | 0.160 |
Why?
|
| 3-Hydroxyacyl CoA Dehydrogenases | 2 | 2002 | 59 | 0.160 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 1667 | 0.160 |
Why?
|
| Microscopy, Electron | 3 | 2014 | 2561 | 0.160 |
Why?
|
| Hydroxocobalamin | 1 | 2018 | 27 | 0.160 |
Why?
|
| Anemia, Megaloblastic | 1 | 2018 | 24 | 0.160 |
Why?
|
| Arginine | 2 | 2018 | 934 | 0.160 |
Why?
|
| Heart-Lung Transplantation | 1 | 1999 | 87 | 0.160 |
Why?
|
| Fibroblasts | 10 | 2018 | 4142 | 0.160 |
Why?
|
| Contracture | 1 | 2021 | 235 | 0.160 |
Why?
|
| Genetic Association Studies | 3 | 2020 | 2735 | 0.160 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2018 | 14 | 0.150 |
Why?
|
| Amino Acid Transport Systems, Acidic | 1 | 2018 | 30 | 0.150 |
Why?
|
| Glucose | 8 | 2001 | 4347 | 0.150 |
Why?
|
| Methylmalonic Acid | 3 | 2006 | 49 | 0.150 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2018 | 26 | 0.150 |
Why?
|
| Neurites | 1 | 2020 | 391 | 0.150 |
Why?
|
| Molecular Sequence Data | 15 | 2013 | 17635 | 0.150 |
Why?
|
| Muscular Atrophy | 1 | 2021 | 334 | 0.150 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2018 | 42 | 0.150 |
Why?
|
| Cation Transport Proteins | 2 | 2018 | 327 | 0.150 |
Why?
|
| Fibroblast Growth Factors | 1 | 2024 | 867 | 0.150 |
Why?
|
| Occupational Diseases | 2 | 2004 | 1490 | 0.150 |
Why?
|
| Genes | 4 | 2000 | 1823 | 0.150 |
Why?
|
| Carbon Isotopes | 6 | 2004 | 458 | 0.150 |
Why?
|
| Parenteral Nutrition | 2 | 2014 | 659 | 0.150 |
Why?
|
| Sequence Deletion | 3 | 2016 | 1494 | 0.150 |
Why?
|
| Naphthalenes | 1 | 1998 | 198 | 0.150 |
Why?
|
| Pedigree | 8 | 2021 | 4542 | 0.150 |
Why?
|
| Diet, Protein-Restricted | 4 | 2014 | 73 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 2791 | 0.140 |
Why?
|
| Psychomotor Disorders | 1 | 2018 | 149 | 0.140 |
Why?
|
| Propionic Acidemia | 1 | 2017 | 9 | 0.140 |
Why?
|
| Lithium Compounds | 2 | 2009 | 223 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 386 | 0.140 |
Why?
|
| Gene Expression | 2 | 2008 | 7581 | 0.140 |
Why?
|
| Liver Transplantation | 3 | 2019 | 2330 | 0.140 |
Why?
|
| Asphyxia | 1 | 2017 | 60 | 0.140 |
Why?
|
| Antiporters | 1 | 2018 | 277 | 0.140 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2018 | 123 | 0.140 |
Why?
|
| Carbohydrate Metabolism | 2 | 2015 | 263 | 0.140 |
Why?
|
| Neurons | 3 | 2014 | 9463 | 0.140 |
Why?
|
| Lissencephaly | 1 | 2016 | 36 | 0.140 |
Why?
|
| Manganese | 2 | 2018 | 393 | 0.140 |
Why?
|
| Adrenal Insufficiency | 1 | 2018 | 194 | 0.140 |
Why?
|
| Siblings | 2 | 2021 | 825 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 2748 | 0.140 |
Why?
|
| Lithium Chloride | 1 | 2016 | 82 | 0.140 |
Why?
|
| Mannosyltransferases | 1 | 2016 | 23 | 0.130 |
Why?
|
| Mice, Knockout | 9 | 2016 | 14417 | 0.130 |
Why?
|
| Cardiomyopathies | 3 | 2020 | 1964 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 1088 | 0.130 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2019 | 547 | 0.130 |
Why?
|
| Oligosaccharides | 1 | 2018 | 406 | 0.130 |
Why?
|
| Potassium Channels | 1 | 2018 | 537 | 0.130 |
Why?
|
| Case-Control Studies | 10 | 2020 | 22176 | 0.130 |
Why?
|
| Lipids | 1 | 2006 | 3341 | 0.130 |
Why?
|
| Nerve Endings | 3 | 1986 | 105 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 2 | 2004 | 1578 | 0.120 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 646 | 0.120 |
Why?
|
| Menkes Kinky Hair Syndrome | 1 | 2014 | 19 | 0.120 |
Why?
|
| Sarcoma, Kaposi | 1 | 1998 | 374 | 0.120 |
Why?
|
| Parkinsonian Disorders | 1 | 2018 | 284 | 0.120 |
Why?
|
| Base Sequence | 14 | 2012 | 12441 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2020 | 17904 | 0.120 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2014 | 383 | 0.120 |
Why?
|
| Middle Aged | 45 | 2024 | 220921 | 0.120 |
Why?
|
| Retrospective Studies | 18 | 2024 | 80647 | 0.120 |
Why?
|
| Asbestos, Serpentine | 1 | 2014 | 24 | 0.120 |
Why?
|
| Glycerol-3-Phosphate Dehydrogenase (NAD+) | 1 | 2014 | 11 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1998 | 678 | 0.120 |
Why?
|
| Physical Endurance | 1 | 2017 | 366 | 0.120 |
Why?
|
| Down Syndrome | 2 | 2000 | 901 | 0.120 |
Why?
|
| Chelating Agents | 2 | 2018 | 387 | 0.110 |
Why?
|
| Microcephaly | 1 | 2018 | 425 | 0.110 |
Why?
|
| Hepatomegaly | 1 | 2014 | 84 | 0.110 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 26 | 0.110 |
Why?
|
| Cheese | 1 | 2014 | 38 | 0.110 |
Why?
|
| Electroencephalography | 7 | 2020 | 6237 | 0.110 |
Why?
|
| Acrodermatitis | 1 | 1993 | 15 | 0.110 |
Why?
|
| Basal Ganglia Diseases | 2 | 1998 | 145 | 0.110 |
Why?
|
| Genetic Counseling | 1 | 2018 | 627 | 0.110 |
Why?
|
| Kidney Diseases | 2 | 2014 | 2091 | 0.110 |
Why?
|
| DNA Primers | 6 | 2013 | 2820 | 0.110 |
Why?
|
| Caseins | 1 | 2014 | 104 | 0.110 |
Why?
|
| Fabaceae | 1 | 2014 | 103 | 0.110 |
Why?
|
| Isoleucine | 1 | 1993 | 110 | 0.110 |
Why?
|
| Pancreatitis | 1 | 2001 | 1096 | 0.110 |
Why?
|
| Tyrosine | 1 | 2018 | 1440 | 0.110 |
Why?
|
| Dystonic Disorders | 1 | 2018 | 350 | 0.110 |
Why?
|
| Autophagy | 2 | 2018 | 1327 | 0.110 |
Why?
|
| Sodium Benzoate | 2 | 2017 | 14 | 0.110 |
Why?
|
| Telomere | 1 | 2000 | 943 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 1134 | 0.110 |
Why?
|
| Growth Disorders | 1 | 2018 | 655 | 0.110 |
Why?
|
| Lysosomes | 1 | 2018 | 924 | 0.110 |
Why?
|
| Acute Disease | 4 | 2018 | 7237 | 0.110 |
Why?
|
| Neuropsychological Tests | 4 | 2020 | 7054 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 3 | 2016 | 411 | 0.110 |
Why?
|
| Tubulin | 1 | 2016 | 693 | 0.110 |
Why?
|
| Sensitivity and Specificity | 4 | 2019 | 14665 | 0.100 |
Why?
|
| Diet Therapy | 1 | 2014 | 151 | 0.100 |
Why?
|
| Hyperargininemia | 1 | 2012 | 12 | 0.100 |
Why?
|
| Kidney Glomerulus | 1 | 1995 | 568 | 0.100 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1999 | 819 | 0.100 |
Why?
|
| Uremia | 1 | 2014 | 201 | 0.100 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2012 | 19 | 0.100 |
Why?
|
| Dicarboxylic Acids | 1 | 1993 | 77 | 0.100 |
Why?
|
| Phospholipase C beta | 1 | 2012 | 49 | 0.100 |
Why?
|
| Motor Activity | 3 | 2020 | 2715 | 0.100 |
Why?
|
| Serotonin | 1 | 2017 | 1041 | 0.100 |
Why?
|
| Nutritional Requirements | 1 | 2014 | 276 | 0.100 |
Why?
|
| Disease Progression | 5 | 2021 | 13510 | 0.100 |
Why?
|
| Phenobarbital | 1 | 2013 | 191 | 0.100 |
Why?
|
| Amino Acid Sequence | 7 | 2013 | 13446 | 0.100 |
Why?
|
| Cricetulus | 1 | 2014 | 814 | 0.100 |
Why?
|
| Inhibins | 1 | 2012 | 210 | 0.100 |
Why?
|
| Open Reading Frames | 3 | 2003 | 815 | 0.100 |
Why?
|
| Hexosyltransferases | 1 | 2012 | 58 | 0.100 |
Why?
|
| Polysaccharides | 2 | 2016 | 1014 | 0.100 |
Why?
|
| Sperm Count | 1 | 2012 | 229 | 0.100 |
Why?
|
| Age of Onset | 4 | 2020 | 3306 | 0.100 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 927 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 878 | 0.100 |
Why?
|
| Diarrhea | 1 | 2018 | 1318 | 0.100 |
Why?
|
| Doxorubicin | 1 | 1998 | 2224 | 0.100 |
Why?
|
| Chromosome Disorders | 1 | 2014 | 497 | 0.090 |
Why?
|
| Inhalation Exposure | 1 | 2014 | 432 | 0.090 |
Why?
|
| Status Epilepticus | 1 | 1997 | 460 | 0.090 |
Why?
|
| Twins, Monozygotic | 1 | 2013 | 470 | 0.090 |
Why?
|
| CHO Cells | 1 | 2014 | 1387 | 0.090 |
Why?
|
| Choroid Plexus | 1 | 2014 | 240 | 0.090 |
Why?
|
| Infertility, Female | 1 | 2017 | 760 | 0.090 |
Why?
|
| Exons | 5 | 2022 | 2391 | 0.090 |
Why?
|
| Genome, Human | 3 | 2013 | 4425 | 0.090 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 1015 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2013 | 446 | 0.090 |
Why?
|
| Water Pollution | 1 | 2010 | 31 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3639 | 0.090 |
Why?
|
| Cerebrospinal Fluid | 1 | 2014 | 544 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 1999 | 1010 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2872 | 0.090 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 293 | 0.090 |
Why?
|
| Antimanic Agents | 2 | 2016 | 520 | 0.090 |
Why?
|
| Environmental Policy | 1 | 2010 | 35 | 0.090 |
Why?
|
| Mitochondria | 5 | 2014 | 3624 | 0.090 |
Why?
|
| Pregnancy, Animal | 1 | 2011 | 124 | 0.090 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2180 | 0.090 |
Why?
|
| Ataxia Telangiectasia | 2 | 2003 | 107 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 802 | 0.090 |
Why?
|
| Acidosis | 4 | 2004 | 268 | 0.090 |
Why?
|
| Cricetinae | 1 | 2014 | 2423 | 0.090 |
Why?
|
| Kinetics | 5 | 2004 | 6374 | 0.090 |
Why?
|
| UDPglucose-Hexose-1-Phosphate Uridylyltransferase | 2 | 2000 | 4 | 0.090 |
Why?
|
| Aspartic Acid | 3 | 2018 | 576 | 0.090 |
Why?
|
| International Cooperation | 1 | 2016 | 1422 | 0.090 |
Why?
|
| Cloning, Molecular | 5 | 2000 | 4174 | 0.090 |
Why?
|
| Research Subjects | 1 | 2012 | 249 | 0.090 |
Why?
|
| Phlorhizin | 3 | 1994 | 37 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2016 | 12973 | 0.090 |
Why?
|
| Xenopus laevis | 1 | 2014 | 963 | 0.080 |
Why?
|
| Semen | 1 | 2012 | 347 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2014 | 1791 | 0.080 |
Why?
|
| Phenylbutyrates | 2 | 2019 | 72 | 0.080 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 496 | 0.080 |
Why?
|
| Globus Pallidus | 2 | 2003 | 250 | 0.080 |
Why?
|
| Hydrolysis | 1 | 2011 | 664 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2013 | 838 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2467 | 0.080 |
Why?
|
| Genetic Markers | 1 | 1996 | 2601 | 0.080 |
Why?
|
| Renal Dialysis | 1 | 1999 | 1796 | 0.080 |
Why?
|
| Cohort Studies | 9 | 2024 | 41495 | 0.080 |
Why?
|
| Cation Exchange Resins | 1 | 2009 | 19 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2014 | 1687 | 0.080 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2008 | 17 | 0.080 |
Why?
|
| Reproducibility of Results | 6 | 2014 | 20100 | 0.080 |
Why?
|
| Limit of Detection | 1 | 2010 | 273 | 0.080 |
Why?
|
| Infant Formula | 1 | 2010 | 194 | 0.080 |
Why?
|
| Codon, Nonsense | 2 | 2021 | 285 | 0.080 |
Why?
|
| Food | 1 | 2014 | 774 | 0.080 |
Why?
|
| Metabolomics | 2 | 2020 | 1659 | 0.080 |
Why?
|
| Malonates | 1 | 1988 | 43 | 0.080 |
Why?
|
| Genetic Testing | 3 | 2020 | 3537 | 0.080 |
Why?
|
| Oocytes | 1 | 2014 | 1166 | 0.080 |
Why?
|
| Tryptophan | 1 | 2011 | 482 | 0.080 |
Why?
|
| Vitamin B 12 Deficiency | 2 | 2018 | 118 | 0.080 |
Why?
|
| Bipolar Disorder | 1 | 2006 | 5092 | 0.080 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2009 | 297 | 0.080 |
Why?
|
| Cell Line | 7 | 2014 | 15601 | 0.080 |
Why?
|
| Leprosy | 1 | 1989 | 126 | 0.080 |
Why?
|
| DNA Copy Number Variations | 2 | 2014 | 2020 | 0.080 |
Why?
|
| Epilepsies, Partial | 1 | 2012 | 431 | 0.080 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2000 | 302 | 0.080 |
Why?
|
| Heterozygote | 7 | 2014 | 2787 | 0.080 |
Why?
|
| Butyryl-CoA Dehydrogenase | 1 | 2007 | 2 | 0.080 |
Why?
|
| Atrophy | 4 | 2021 | 1633 | 0.080 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2004 | 353 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 3713 | 0.070 |
Why?
|
| Age Factors | 8 | 2014 | 18399 | 0.070 |
Why?
|
| Truth Disclosure | 1 | 2012 | 434 | 0.070 |
Why?
|
| NADP | 1 | 2008 | 227 | 0.070 |
Why?
|
| Cytosine Nucleotides | 2 | 1986 | 10 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2014 | 790 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2008 | 726 | 0.070 |
Why?
|
| Cytidine Monophosphate | 2 | 1986 | 11 | 0.070 |
Why?
|
| Infant Nutrition Disorders | 1 | 2008 | 70 | 0.070 |
Why?
|
| Founder Effect | 1 | 2007 | 186 | 0.070 |
Why?
|
| Fruit | 1 | 1993 | 1160 | 0.070 |
Why?
|
| Vegetables | 1 | 1993 | 1195 | 0.070 |
Why?
|
| Vertebrates | 1 | 2008 | 227 | 0.070 |
Why?
|
| Dogs | 3 | 1997 | 3839 | 0.070 |
Why?
|
| Endothelial Cells | 1 | 2020 | 3549 | 0.070 |
Why?
|
| Asbestos | 2 | 1979 | 251 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 2457 | 0.070 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 1988 | 174 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2012 | 697 | 0.070 |
Why?
|
| Polymorphism, Genetic | 3 | 2017 | 4243 | 0.070 |
Why?
|
| Policy Making | 1 | 2010 | 542 | 0.070 |
Why?
|
| Pediatrics | 1 | 2022 | 3589 | 0.070 |
Why?
|
| RNA, Messenger | 4 | 2016 | 12794 | 0.070 |
Why?
|
| Dietary Proteins | 3 | 2001 | 952 | 0.070 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 1986 | 36 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2017 | 2922 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2021 | 5799 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 5790 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 2865 | 0.070 |
Why?
|
| Ketoses | 1 | 2005 | 3 | 0.070 |
Why?
|
| Energy Intake | 1 | 2014 | 2134 | 0.070 |
Why?
|
| Fetus | 1 | 1993 | 1863 | 0.070 |
Why?
|
| Endothelium, Vascular | 2 | 2020 | 4431 | 0.070 |
Why?
|
| Oxidoreductases | 1 | 1988 | 413 | 0.070 |
Why?
|
| BCG Vaccine | 1 | 1989 | 369 | 0.060 |
Why?
|
| Treatment Outcome | 9 | 2018 | 64685 | 0.060 |
Why?
|
| Zebrafish | 1 | 2017 | 3008 | 0.060 |
Why?
|
| Jews | 1 | 2007 | 356 | 0.060 |
Why?
|
| Models, Biological | 1 | 2022 | 9469 | 0.060 |
Why?
|
| Thrombosis | 1 | 2020 | 2942 | 0.060 |
Why?
|
| Myocardium | 2 | 1998 | 4725 | 0.060 |
Why?
|
| Disease Management | 4 | 2018 | 2508 | 0.060 |
Why?
|
| Acyl-CoA Dehydrogenase | 2 | 2003 | 57 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2010 | 803 | 0.060 |
Why?
|
| Australia | 6 | 2014 | 1250 | 0.060 |
Why?
|
| Critical Care | 1 | 2018 | 2697 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2020 | 10090 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2004 | 1755 | 0.060 |
Why?
|
| Antioxidants | 1 | 2013 | 1668 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 3 | 2000 | 1200 | 0.060 |
Why?
|
| Tremor | 1 | 2006 | 191 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2012 | 1742 | 0.060 |
Why?
|
| Reference Standards | 1 | 2009 | 1003 | 0.060 |
Why?
|
| Heart | 1 | 1998 | 4404 | 0.060 |
Why?
|
| Brain Mapping | 1 | 2020 | 6635 | 0.060 |
Why?
|
| Adenosine Triphosphatases | 2 | 2022 | 836 | 0.060 |
Why?
|
| NAD | 1 | 2008 | 614 | 0.060 |
Why?
|
| Kidney | 6 | 2014 | 7048 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2012 | 2203 | 0.060 |
Why?
|
| Western Australia | 1 | 2004 | 41 | 0.060 |
Why?
|
| Leukocytes | 4 | 2018 | 2026 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 5 | 2013 | 22174 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4671 | 0.060 |
Why?
|
| Citrate (si)-Synthase | 1 | 2004 | 48 | 0.060 |
Why?
|
| Textile Industry | 1 | 2004 | 74 | 0.060 |
Why?
|
| Tissue Extracts | 1 | 2004 | 141 | 0.060 |
Why?
|
| Cystinosis | 1 | 2004 | 26 | 0.060 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2018 | 473 | 0.060 |
Why?
|
| Sorbitol | 1 | 2023 | 57 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 7391 | 0.060 |
Why?
|
| Dietary Carbohydrates | 4 | 2012 | 891 | 0.050 |
Why?
|
| Progesterone | 1 | 2008 | 742 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2003 | 31 | 0.050 |
Why?
|
| DNA Mutational Analysis | 4 | 2005 | 4111 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2003 | 30 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2018 | 3415 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2003 | 43 | 0.050 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 2003 | 88 | 0.050 |
Why?
|
| Electron Transport | 1 | 2004 | 210 | 0.050 |
Why?
|
| Hydroxybutyrates | 1 | 2003 | 79 | 0.050 |
Why?
|
| Cross-Sectional Studies | 6 | 2024 | 26129 | 0.050 |
Why?
|
| Infusion Pumps | 1 | 2004 | 163 | 0.050 |
Why?
|
| Lactates | 1 | 2004 | 405 | 0.050 |
Why?
|
| Sucrose | 1 | 2023 | 158 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 39106 | 0.050 |
Why?
|
| Mortality | 2 | 2004 | 2902 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2001 | 1646 | 0.050 |
Why?
|
| Early Diagnosis | 2 | 2018 | 1186 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18255 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2012 | 1606 | 0.050 |
Why?
|
| Phentolamine | 1 | 1982 | 102 | 0.050 |
Why?
|
| Biliary Atresia | 1 | 2002 | 88 | 0.050 |
Why?
|
| Asbestosis | 2 | 1979 | 81 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2024 | 9542 | 0.050 |
Why?
|
| Allergens | 2 | 2000 | 1432 | 0.050 |
Why?
|
| Cerebrovascular Disorders | 1 | 1988 | 1474 | 0.050 |
Why?
|
| Leucine | 2 | 2001 | 548 | 0.050 |
Why?
|
| Ketone Bodies | 1 | 2001 | 76 | 0.050 |
Why?
|
| Frameshift Mutation | 2 | 2020 | 392 | 0.050 |
Why?
|
| Testosterone | 1 | 2012 | 2472 | 0.050 |
Why?
|
| Autopsy | 2 | 2017 | 1009 | 0.050 |
Why?
|
| Diet | 4 | 2014 | 8075 | 0.050 |
Why?
|
| Syndrome | 4 | 2013 | 3267 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6992 | 0.050 |
Why?
|
| Hypertension, Portal | 1 | 2004 | 226 | 0.050 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 1379 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2000 | 2510 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 1999 | 659 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 2472 | 0.050 |
Why?
|
| Hematoma, Subdural | 3 | 1986 | 127 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 7968 | 0.050 |
Why?
|
| Cardiomegaly | 1 | 2004 | 590 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3429 | 0.050 |
Why?
|
| Estrogens | 1 | 2008 | 1522 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2003 | 542 | 0.050 |
Why?
|
| Phylogeny | 1 | 2008 | 2811 | 0.050 |
Why?
|
| Amylases | 1 | 2001 | 171 | 0.050 |
Why?
|
| Ligases | 2 | 1995 | 333 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2001 | 6075 | 0.040 |
Why?
|
| Enteral Nutrition | 2 | 2001 | 794 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2001 | 777 | 0.040 |
Why?
|
| Aged | 18 | 2020 | 169310 | 0.040 |
Why?
|
| Time Factors | 7 | 2014 | 39969 | 0.040 |
Why?
|
| Cattle | 3 | 1996 | 3849 | 0.040 |
Why?
|
| Rats | 9 | 2013 | 23741 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2008 | 1819 | 0.040 |
Why?
|
| Postoperative Complications | 2 | 2000 | 15633 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2001 | 436 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2003 | 1262 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase | 2 | 1997 | 26 | 0.040 |
Why?
|
| Transplantation, Heterotopic | 1 | 2000 | 174 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2006 | 1420 | 0.040 |
Why?
|
| Diet, Vegetarian | 1 | 2001 | 180 | 0.040 |
Why?
|
| Electromyography | 2 | 2003 | 1394 | 0.040 |
Why?
|
| Evidence-Based Medicine | 3 | 2016 | 3688 | 0.040 |
Why?
|
| RNA, Transfer, Leu | 1 | 1999 | 13 | 0.040 |
Why?
|
| Cross Infection | 1 | 1988 | 1422 | 0.040 |
Why?
|
| DAX-1 Orphan Nuclear Receptor | 1 | 2018 | 29 | 0.040 |
Why?
|
| Glycerophospholipids | 1 | 1999 | 38 | 0.040 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 12690 | 0.040 |
Why?
|
| Mitochondrial Myopathies | 1 | 1999 | 50 | 0.040 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2000 | 304 | 0.040 |
Why?
|
| Cerebellum | 2 | 2003 | 1501 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2006 | 783 | 0.040 |
Why?
|
| Cerebellar Diseases | 1 | 2021 | 220 | 0.040 |
Why?
|
| Reference Values | 6 | 2011 | 4920 | 0.040 |
Why?
|
| Cells, Cultured | 6 | 2018 | 18966 | 0.040 |
Why?
|
| Glycine | 2 | 1995 | 663 | 0.040 |
Why?
|
| Lipase | 1 | 2001 | 325 | 0.040 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2018 | 26 | 0.040 |
Why?
|
| Spinal Cord Diseases | 1 | 2001 | 292 | 0.040 |
Why?
|
| Folate Receptor 1 | 1 | 2018 | 40 | 0.040 |
Why?
|
| Anticonvulsants | 3 | 2013 | 1906 | 0.040 |
Why?
|
| Fetal Diseases | 1 | 2004 | 913 | 0.040 |
Why?
|
| Ataxia | 1 | 2020 | 306 | 0.040 |
Why?
|
| Growth | 2 | 1992 | 365 | 0.040 |
Why?
|
| New Zealand | 1 | 1999 | 358 | 0.040 |
Why?
|
| Emergency Medicine | 2 | 2018 | 1198 | 0.040 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 1519 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2001 | 323 | 0.040 |
Why?
|
| Tetrahydrofolates | 1 | 2018 | 58 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2003 | 1170 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 422 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2005 | 2612 | 0.040 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 1997 | 40 | 0.040 |
Why?
|
| Hydroxyindoleacetic Acid | 1 | 2017 | 93 | 0.040 |
Why?
|
| Failure to Thrive | 1 | 2018 | 140 | 0.040 |
Why?
|
| Biopsy | 3 | 2004 | 6766 | 0.040 |
Why?
|
| Sleep | 1 | 2013 | 4768 | 0.040 |
Why?
|
| Mood Disorders | 1 | 2004 | 1127 | 0.040 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1997 | 100 | 0.040 |
Why?
|
| Hematologic Tests | 1 | 2018 | 239 | 0.040 |
Why?
|
| Th1 Cells | 2 | 2000 | 1036 | 0.040 |
Why?
|
| China | 2 | 1999 | 2374 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 554 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1674 | 0.030 |
Why?
|
| Th2 Cells | 2 | 2000 | 1060 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2001 | 748 | 0.030 |
Why?
|
| Anisotropy | 1 | 2020 | 1283 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2217 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2000 | 1991 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 1996 | 154 | 0.030 |
Why?
|
| Brain Stem | 2 | 2017 | 858 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36426 | 0.030 |
Why?
|
| Plasma | 1 | 2020 | 586 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 437 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2018 | 523 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2020 | 773 | 0.030 |
Why?
|
| Hematoma, Epidural, Cranial | 2 | 1986 | 59 | 0.030 |
Why?
|
| Lactose | 1 | 1996 | 95 | 0.030 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1996 | 79 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 2018 | 244 | 0.030 |
Why?
|
| Vitamin B 12 | 2 | 2014 | 524 | 0.030 |
Why?
|
| Cystathionine beta-Synthase | 1 | 1995 | 27 | 0.030 |
Why?
|
| Glutamates | 1 | 2017 | 389 | 0.030 |
Why?
|
| Genes, Lethal | 1 | 2016 | 223 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2004 | 6345 | 0.030 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2017 | 324 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2016 | 1171 | 0.030 |
Why?
|
| Carbon-Carbon Ligases | 1 | 1995 | 19 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13642 | 0.030 |
Why?
|
| North America | 1 | 1999 | 1276 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 9420 | 0.030 |
Why?
|
| Pyridoxine | 1 | 1995 | 108 | 0.030 |
Why?
|
| MELAS Syndrome | 1 | 1995 | 56 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 9610 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 3076 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 2 | 2014 | 2178 | 0.030 |
Why?
|
| Edema | 1 | 1999 | 766 | 0.030 |
Why?
|
| Intelligence | 2 | 1991 | 924 | 0.030 |
Why?
|
| Phloretin | 1 | 1994 | 16 | 0.030 |
Why?
|
| Liposomes | 1 | 1998 | 783 | 0.030 |
Why?
|
| Genes, myb | 1 | 2013 | 18 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1998 | 7593 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 1762 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 1995 | 159 | 0.030 |
Why?
|
| Hyperinsulinism | 1 | 1997 | 400 | 0.030 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2014 | 82 | 0.030 |
Why?
|
| Hepatitis B, Chronic | 1 | 1998 | 410 | 0.030 |
Why?
|
| Peptide Elongation Factors | 1 | 2013 | 62 | 0.030 |
Why?
|
| Drug Carriers | 1 | 1998 | 706 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1994 | 328 | 0.030 |
Why?
|
| Hippocampus | 1 | 2006 | 3766 | 0.030 |
Why?
|
| Craniocerebral Trauma | 3 | 1986 | 490 | 0.030 |
Why?
|
| Nephritis | 1 | 2014 | 145 | 0.030 |
Why?
|
| Biological Transport | 2 | 1998 | 2091 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4176 | 0.030 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2013 | 223 | 0.030 |
Why?
|
| Risk Factors | 6 | 2017 | 74213 | 0.030 |
Why?
|
| Infant Food | 1 | 1993 | 140 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2927 | 0.030 |
Why?
|
| Lung | 3 | 2003 | 10002 | 0.030 |
Why?
|
| Age Distribution | 1 | 1999 | 2879 | 0.030 |
Why?
|
| Amino Acids | 1 | 1999 | 1718 | 0.030 |
Why?
|
| Carnitine Acyltransferases | 1 | 1992 | 8 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2003 | 3442 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2020 | 3968 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 371 | 0.030 |
Why?
|
| Prognosis | 9 | 2018 | 29629 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11076 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23447 | 0.030 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15843 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 1998 | 2850 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2013 | 367 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 1561 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2006 | 4446 | 0.030 |
Why?
|
| Bacteriophages | 1 | 1996 | 378 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2013 | 110 | 0.030 |
Why?
|
| Prone Position | 1 | 2013 | 196 | 0.030 |
Why?
|
| Prospective Studies | 4 | 2024 | 54423 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2016 | 697 | 0.030 |
Why?
|
| Italy | 1 | 2014 | 842 | 0.020 |
Why?
|
| Nephritis, Interstitial | 1 | 2013 | 155 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2006 | 3233 | 0.020 |
Why?
|
| Ubiquinone | 1 | 2013 | 183 | 0.020 |
Why?
|
| Europe | 1 | 1999 | 3420 | 0.020 |
Why?
|
| Incidence | 5 | 2017 | 21355 | 0.020 |
Why?
|
| Sodium Potassium Chloride Symporter Inhibitors | 1 | 2013 | 152 | 0.020 |
Why?
|
| Analysis of Variance | 3 | 2008 | 6228 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1998 | 1363 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1997 | 710 | 0.020 |
Why?
|
| Retinal Diseases | 1 | 1998 | 705 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2003 | 3575 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2018 | 1301 | 0.020 |
Why?
|
| Culture Media | 1 | 1993 | 897 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 695 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2013 | 397 | 0.020 |
Why?
|
| Blood Glucose | 3 | 2001 | 6391 | 0.020 |
Why?
|
| Albuminuria | 1 | 1995 | 658 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2898 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 20568 | 0.020 |
Why?
|
| Glucosyltransferases | 1 | 1991 | 95 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1983 | 2088 | 0.020 |
Why?
|
| Echocardiography | 1 | 2004 | 4989 | 0.020 |
Why?
|
| Acetonitriles | 1 | 2011 | 54 | 0.020 |
Why?
|
| Water Pollutants | 1 | 2010 | 24 | 0.020 |
Why?
|
| Fetal Hemoglobin | 1 | 2013 | 345 | 0.020 |
Why?
|
| Blood | 1 | 1993 | 596 | 0.020 |
Why?
|
| Hospital Bed Capacity | 2 | 1988 | 206 | 0.020 |
Why?
|
| Language | 1 | 2020 | 1543 | 0.020 |
Why?
|
| Transferrin | 1 | 2012 | 283 | 0.020 |
Why?
|
| Ovarian Diseases | 1 | 2012 | 137 | 0.020 |
Why?
|
| Fresh Water | 1 | 2010 | 82 | 0.020 |
Why?
|
| Electron Transport Complex IV | 3 | 1997 | 190 | 0.020 |
Why?
|
| Cell Division | 2 | 1999 | 4465 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2013 | 750 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 2112 | 0.020 |
Why?
|
| Leigh Disease | 1 | 1991 | 89 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2011 | 369 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2014 | 793 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 1993 | 540 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2011 | 383 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2001 | 5485 | 0.020 |
Why?
|
| Respiration Disorders | 1 | 2013 | 367 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 1998 | 1032 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2018 | 1779 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 6131 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2003 | 6241 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1995 | 1968 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2008 | 12953 | 0.020 |
Why?
|
| Stem Cells | 1 | 2003 | 3524 | 0.020 |
Why?
|
| Brain Diseases | 1 | 1999 | 1546 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 1010 | 0.020 |
Why?
|
| Hospitalization | 3 | 2012 | 10721 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 12149 | 0.020 |
Why?
|
| Phosphotransferases | 2 | 1991 | 303 | 0.020 |
Why?
|
| Prevalence | 3 | 1999 | 15733 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 2199 | 0.020 |
Why?
|
| Carbon Radioisotopes | 2 | 2001 | 561 | 0.020 |
Why?
|
| Isotope Labeling | 1 | 2011 | 392 | 0.020 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 1991 | 435 | 0.020 |
Why?
|
| Dehydration | 1 | 1991 | 216 | 0.020 |
Why?
|
| Water Supply | 1 | 2010 | 204 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 951 | 0.020 |
Why?
|
| Papua New Guinea | 1 | 1989 | 46 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2018 | 1841 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 2012 | 334 | 0.020 |
Why?
|
| Energy Metabolism | 2 | 1998 | 2882 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14608 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 1281 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3810 | 0.020 |
Why?
|
| Binding Sites | 1 | 1997 | 6056 | 0.020 |
Why?
|
| Isovaleryl-CoA Dehydrogenase | 1 | 1988 | 4 | 0.020 |
Why?
|
| Phospholipids | 2 | 1983 | 786 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1757 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2001 | 8527 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2010 | 193 | 0.020 |
Why?
|
| Creatine | 2 | 2003 | 427 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3113 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 910 | 0.020 |
Why?
|
| Pilocarpine | 1 | 2008 | 64 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2017 | 818 | 0.020 |
Why?
|
| Hormones | 1 | 2012 | 869 | 0.020 |
Why?
|
| Chromatography, Gas | 2 | 2000 | 151 | 0.020 |
Why?
|
| Cryopreservation | 1 | 2013 | 728 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2014 | 1432 | 0.020 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2007 | 5 | 0.020 |
Why?
|
| Biotin | 1 | 1989 | 253 | 0.020 |
Why?
|
| Ovalbumin | 2 | 2000 | 677 | 0.020 |
Why?
|
| Biodiversity | 1 | 2010 | 347 | 0.020 |
Why?
|
| Citrullinemia | 1 | 2007 | 3 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1991 | 926 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1679 | 0.020 |
Why?
|
| Autistic Disorder | 2 | 2010 | 1220 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 2677 | 0.020 |
Why?
|
| Anthropometry | 1 | 2012 | 1349 | 0.020 |
Why?
|
| Swimming | 1 | 2008 | 208 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2001 | 9319 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2013 | 1047 | 0.020 |
Why?
|
| Insulin | 1 | 2001 | 6597 | 0.020 |
Why?
|
| CDP-Diacylglycerol-Inositol 3-Phosphatidyltransferase | 1 | 1986 | 3 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3600 | 0.020 |
Why?
|
| Choline | 2 | 1999 | 515 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 4615 | 0.020 |
Why?
|
| Odds Ratio | 1 | 1999 | 9647 | 0.020 |
Why?
|
| Internationality | 1 | 2012 | 1001 | 0.020 |
Why?
|
| Carbon Dioxide | 2 | 2001 | 1147 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2006 | 201 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2001 | 3708 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2012 | 1738 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 5035 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1998 | 2297 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 3779 | 0.020 |
Why?
|
| Aorta | 1 | 1993 | 2041 | 0.020 |
Why?
|
| Trachea | 1 | 1991 | 1089 | 0.020 |
Why?
|
| Georgia | 1 | 2005 | 185 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 1995 | 329 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 993 | 0.020 |
Why?
|
| Hip Joint | 1 | 2012 | 1014 | 0.020 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2010 | 600 | 0.020 |
Why?
|
| Mosaicism | 1 | 1988 | 475 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 1902 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1998 | 5971 | 0.020 |
Why?
|
| Skull Fractures | 4 | 1986 | 202 | 0.020 |
Why?
|
| Fixation, Ocular | 4 | 1986 | 242 | 0.010 |
Why?
|
| Mitochondria, Muscle | 2 | 1999 | 172 | 0.010 |
Why?
|
| Cysteamine | 1 | 2004 | 24 | 0.010 |
Why?
|
| Social Behavior | 1 | 2011 | 1135 | 0.010 |
Why?
|
| Random Allocation | 1 | 1989 | 2395 | 0.010 |
Why?
|
| Protons | 2 | 2001 | 1116 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 15266 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
| Epidemiologic Methods | 2 | 1979 | 1336 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1988 | 1386 | 0.010 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2003 | 5 | 0.010 |
Why?
|
| Ketone Oxidoreductases | 1 | 2003 | 5 | 0.010 |
Why?
|
| Nucleotides | 1 | 1986 | 454 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1983 | 89 | 0.010 |
Why?
|
| Kupffer Cells | 1 | 2004 | 143 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2011 | 1436 | 0.010 |
Why?
|
| Peptides | 1 | 1995 | 4358 | 0.010 |
Why?
|
| Muscular Diseases | 1 | 2007 | 553 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2003 | 80 | 0.010 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2002 | 22 | 0.010 |
Why?
|
| Spinal Injuries | 1 | 1986 | 301 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6312 | 0.010 |
Why?
|
| Cause of Death | 1 | 2013 | 3683 | 0.010 |
Why?
|
| Sex Factors | 3 | 2012 | 10554 | 0.010 |
Why?
|
| Quality of Life | 2 | 2017 | 13367 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2003 | 261 | 0.010 |
Why?
|
| Inflammation | 2 | 2000 | 10774 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10508 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1998 | 4317 | 0.010 |
Why?
|
| Mass Screening | 1 | 1998 | 5429 | 0.010 |
Why?
|
| Body Composition | 1 | 1992 | 2426 | 0.010 |
Why?
|
| Language Disorders | 1 | 2003 | 140 | 0.010 |
Why?
|
| Research | 1 | 2010 | 1982 | 0.010 |
Why?
|
| Calcium | 2 | 2012 | 5722 | 0.010 |
Why?
|
| Health Surveys | 2 | 1988 | 4061 | 0.010 |
Why?
|
| Succinate-Semialdehyde Dehydrogenase | 1 | 2003 | 96 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8181 | 0.010 |
Why?
|
| Animals, Suckling | 1 | 2001 | 69 | 0.010 |
Why?
|
| Infection Control | 1 | 1988 | 982 | 0.010 |
Why?
|
| United States | 3 | 2020 | 72340 | 0.010 |
Why?
|
| Psychometrics | 1 | 2011 | 3065 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9327 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2018 | 23996 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2000 | 6214 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 2003 | 623 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 11904 | 0.010 |
Why?
|
| Weight Loss | 1 | 1992 | 2684 | 0.010 |
Why?
|
| Markov Chains | 1 | 2003 | 966 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2000 | 455 | 0.010 |
Why?
|
| Skin | 1 | 1994 | 4484 | 0.010 |
Why?
|
| Physicians | 1 | 2018 | 4591 | 0.010 |
Why?
|
| Phosphates | 1 | 1983 | 770 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 413 | 0.010 |
Why?
|
| Cerebral Cortex | 2 | 2003 | 5779 | 0.010 |
Why?
|
| Recurrence | 1 | 2012 | 8466 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1882 | 0.010 |
Why?
|
| Models, Animal | 1 | 2006 | 2112 | 0.010 |
Why?
|
| Asthma | 1 | 1999 | 6234 | 0.010 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 666 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1999 | 100 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1981 | 629 | 0.010 |
Why?
|
| Food, Formulated | 1 | 1980 | 101 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 1988 | 1529 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 1999 | 124 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2012 | 3415 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 891 | 0.010 |
Why?
|
| Bone Density | 1 | 2012 | 3551 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2006 | 1844 | 0.010 |
Why?
|
| Patient Admission | 4 | 1986 | 1367 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1998 | 82 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 1999 | 220 | 0.010 |
Why?
|
| London | 1 | 1979 | 234 | 0.010 |
Why?
|
| Muscles | 2 | 1995 | 1576 | 0.010 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1998 | 64 | 0.010 |
Why?
|
| Spinal Cord Injuries | 1 | 1986 | 925 | 0.010 |
Why?
|
| Vitamin D | 1 | 2012 | 3303 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 2 | 2003 | 5493 | 0.010 |
Why?
|
| RNA, Transfer, Lys | 1 | 1997 | 8 | 0.010 |
Why?
|
| Creatinine | 1 | 2004 | 1899 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1999 | 767 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 6534 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2012 | 3980 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2003 | 1139 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 698 | 0.010 |
Why?
|
| Hypertension | 1 | 1998 | 8540 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 981 | 0.010 |
Why?
|
| England | 1 | 1979 | 526 | 0.010 |
Why?
|
| Cathepsin A | 1 | 1996 | 4 | 0.010 |
Why?
|
| Aging | 2 | 1994 | 8710 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 1998 | 95 | 0.010 |
Why?
|
| Algorithms | 1 | 2018 | 14033 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2003 | 1722 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2003 | 1141 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 2358 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2001 | 1093 | 0.010 |
Why?
|
| Retinal Vein Occlusion | 1 | 1998 | 149 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 1149 | 0.010 |
Why?
|
| Pulse | 2 | 1986 | 217 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2011 | 5079 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1625 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 1227 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1995 | 52 | 0.010 |
Why?
|
| Glycosuria | 1 | 1995 | 44 | 0.010 |
Why?
|
| Biotinidase | 1 | 1995 | 17 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1739 | 0.010 |
Why?
|
| Food, Fortified | 1 | 1996 | 190 | 0.010 |
Why?
|
| Succinate Dehydrogenase | 1 | 1995 | 145 | 0.010 |
Why?
|
| Nitrogen | 1 | 1996 | 348 | 0.010 |
Why?
|
| Aneurysm | 1 | 1998 | 337 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1529 | 0.010 |
Why?
|
| Brain Injuries | 1 | 1986 | 2054 | 0.010 |
Why?
|
| Shock | 2 | 1986 | 314 | 0.010 |
Why?
|
| Eosinophils | 1 | 1999 | 950 | 0.010 |
Why?
|
| Hemiterpenes | 1 | 1993 | 18 | 0.010 |
Why?
|
| Pentanoic Acids | 1 | 1993 | 17 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1999 | 2626 | 0.010 |
Why?
|
| Acyl Coenzyme A | 1 | 1993 | 56 | 0.010 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 1993 | 49 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3792 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1997 | 2496 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 8002 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2001 | 2571 | 0.010 |
Why?
|
| Membranes | 1 | 1992 | 165 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2002 | 1935 | 0.010 |
Why?
|
| Radiography | 1 | 2003 | 6965 | 0.010 |
Why?
|
| Retinal Vessels | 1 | 1998 | 852 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2000 | 3162 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1992 | 411 | 0.010 |
Why?
|
| DNA | 2 | 2000 | 7213 | 0.010 |
Why?
|
| Carbachol | 1 | 1991 | 223 | 0.010 |
Why?
|
| Trichloroacetic Acid | 1 | 1991 | 48 | 0.010 |
Why?
|
| Schizophrenia | 1 | 2010 | 6937 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2000 | 2302 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 1998 | 58984 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1979 | 954 | 0.010 |
Why?
|
| Calmodulin | 1 | 1991 | 218 | 0.010 |
Why?
|
| Phosphorus | 1 | 1992 | 335 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 1998 | 1315 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3396 | 0.010 |
Why?
|
| Transfection | 1 | 1998 | 5774 | 0.010 |
Why?
|
| Blood Preservation | 1 | 1991 | 169 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2000 | 5439 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1991 | 503 | 0.010 |
Why?
|
| Cephalometry | 1 | 1992 | 382 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1992 | 390 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 1999 | 1171 | 0.010 |
Why?
|
| Obesity | 1 | 1992 | 12947 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1998 | 3687 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 550 | 0.000 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 4235 | 0.000 |
Why?
|
| Twins, Dizygotic | 1 | 1989 | 236 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1995 | 4021 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1302 | 0.000 |
Why?
|
| Muscle Contraction | 1 | 1991 | 1201 | 0.000 |
Why?
|
| Diuretics, Osmotic | 1 | 1986 | 33 | 0.000 |
Why?
|
| Nutritional Status | 1 | 1995 | 1615 | 0.000 |
Why?
|
| Ambulances | 1 | 1986 | 91 | 0.000 |
Why?
|
| Accidents | 1 | 1986 | 165 | 0.000 |
Why?
|
| Rabbits | 1 | 1991 | 4772 | 0.000 |
Why?
|
| Transportation of Patients | 1 | 1986 | 174 | 0.000 |
Why?
|
| Diagnosis-Related Groups | 1 | 1986 | 449 | 0.000 |
Why?
|
| Hospitals, Rural | 1 | 1986 | 176 | 0.000 |
Why?
|
| Cytokines | 1 | 1999 | 7396 | 0.000 |
Why?
|
| Thoracic Injuries | 1 | 1986 | 288 | 0.000 |
Why?
|
| Survival Rate | 1 | 1996 | 12723 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 1996 | 12463 | 0.000 |
Why?
|
| Smoking | 1 | 1979 | 9053 | 0.000 |
Why?
|
| Hospitals, Teaching | 1 | 1986 | 1156 | 0.000 |
Why?
|
| Probability | 1 | 1986 | 2477 | 0.000 |
Why?
|
| Accidents, Traffic | 1 | 1986 | 816 | 0.000 |
Why?
|
| Consciousness | 1 | 1986 | 601 | 0.000 |
Why?
|
| Blood Pressure | 2 | 1986 | 8481 | 0.000 |
Why?
|
| Hypotension | 1 | 1986 | 879 | 0.000 |
Why?
|
| Adipose Tissue | 1 | 1992 | 3313 | 0.000 |
Why?
|
| Citrates | 1 | 1980 | 134 | 0.000 |
Why?
|
| Transcription Factors | 1 | 1998 | 12130 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1979 | 13381 | 0.000 |
Why?
|
| Neoplasms | 1 | 1979 | 22173 | 0.000 |
Why?
|
| Emergency Service, Hospital | 1 | 1986 | 7879 | 0.000 |
Why?
|